The bill approves the final rulemaking for the District of Columbia's Medical Cannabis Remediation and Testing, allowing businesses to remediate.
The District of Columbia's Medical Cannabis Remediation and Testing Rulemaking Approval Resolution of 2025 allows licensed medical cannabis businesses to remediate cannabis and cannabis products that fail testing for certain reasons. This resolution follows emergency rules that were adopted to maintain existing rules while permanent rules were developed. The final rules, which were approved by the Alcoholic Beverage and Cannabis Board, allow for the remediation of cannabis that fails testing for microbiological, mycotoxin, heavy metal, or residual solvent issues, provided the failure was not.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.